Table 3.

Cox regression analysis for investigating the correlation between USP19 expression and BRCA1/2 mutation and progression-free survival.

Cohort	Model	Variable	Coefficient	Exp (coef.) = Hazard Ratio	SE (coef.)	p-Value
This study (n = 42)	USP19 exp.	USP19	−0.040	0.96	0.014	0.0048 *
	BRCA mutation	BRCA	−0.15	0.86	0.35	0.67
	USP19 exp. + BRCA mutation	USP19 #	−0.056	0.95	0.018	0.0018 *
		BRCA	0.73	2.07	0.45	0.10
TCGA (n = 134)	USP19 exp.	USP19	−0.014	0.99	0.0085	0.091
	BRCA mutation	BRCA	−0.62	0.54	0.35	0.081
	USP19 exp. + BRCA mutation	USP19 #	−0.023	0.98	0.0097	0.017 *
		BRCA	−0.89	0.41	0.38	0.018 *

^# USP19 expression after adjusting the BRCA1/2 mutation status. * p < 0.05.